DAZODALIBEP
UNII HN5US76BWF

Substance Identification & Data

This profile provides standardized clinical and technical data for Dazodalibep, uniquely identified by the FDA Unique Ingredient Identifier (UNII) HN5US76BWF.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2245953-10-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

HN5US76BWF

CAS Registry Number

2245953-10-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DAZODALIBEP

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C175714

National Cancer Institute reference terminology for clinical and research data.

INN ID

11399

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

GH-123

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dazodalibep. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DAZODALIBEP

Common Names & Synonyms

DAZODALIBEP [INN]

DAZODALIBEP [USAN]

DAZODALIBEP [WHO-DD]

PROTEIN VIB4920 (RECOMBINANT HUMAN TENASCIN C CD40 LIGAND-BINDING THIRD FIBRONECTIN TYPE III DOMAIN) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC 19-AMINO ACID LINKER) FUSION PROTEIN WITH TENASCIN C CD40 LIGAND-BINDING THIRD FIBRONECTIN TYPE III DOMAIN (HUMAN RECOMBINANT) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC 10-AMINO ACID LINKER) FUSION PROTEIN WITH SERUM ALBUMIN (HUMAN C-TERMINAL FRAGMENT)